Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening. Objectives: ...

Cancer is the second leading cause of death within the US. The sooner it is detected through screening, the sooner it can be ...

Hot off the trail of National Breast Cancer Month in October, one company is trying to ease the detection of the disease that has been projected to impact at least 316,950 women across the country in ...

Oncodetect uses whole exome sequencing to analyze circulating tumor DNA, providing quantitative insights into disease status for informed treatment decisions. The test offers a "Detected" or "Not ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer, today announced ...

SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...